Dna,Helix,3d,Illustration.,Mutations,Under,Microscope.,Decoding,Genome.,Virtual

Rewriting eye disease: Are we ready for gene therapies?

In 2020, ophthalmology became the first medical field in Australia to secure approval for a gene therapy. The one-off treatment can restore vision in people once resigned to a lifetime of blindness and is expected to pave the way for many more. MYLES HUME analyses the opportunities and challenges posed by ocular gene therapies. Read more

 Second national eye health survey announced

A second National Eye Health Survey has been announced – this time with an added ear health component – and will examine close to 5,000 Aboriginal and Torres Strait Islander peoples and non-Aboriginal Australians over two years. Read more

cornea nerve damage long covid

Long COVID link to corneal nerve damage

Nerve fibre loss and an increase in key immune cells on the cornea may be an identifying feature of ‘long COVID’, suggests a small study published in the British Journal of Ophthalmology. Read more